Toward a Shared Vision for Cancer Genomic Data
Open accessThe DOI matches its Crossref record; 6 of the 7 references it cites were found in a registry or an index.
Abstract
This FAIRsharing record describes: The National Cancer Institute’s (NCI’s) Genomic Data Commons (GDC) is a data sharing The National Cancer Institute's Genomic Data Commons (GDC) was created to promote precision medicine in oncology. It supports the import and standardization of genomic and clinical data from cancer research programs. The GDC contains NCI-generated data from some of the largest and most comprehensive cancer genomic datasets, including The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Therapies (TARGET). For the first time, these datasets have been harmonized using a common set of bioinformatics pipelines, so that the data can be directly compared. As a growing knowledge system for cancer, the GDC also enables researchers to submit data, and harmonizes these data for import into the GDC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Again, the MEKi bypass resistance was strongly correlated with the SRC activation/dasatinib sensitivity, the EMT-like stemness and the CMS4 subtype (see Fig. 6 and Fig. 7 as well as Additional File 3_Fig S5 and Fig S6).”
From An integrative gene expression signature analysis identifies CMS4 KRAS-mutated colorectal cancers sensitive to combined MEK and SRC targeted therapy (2022) · cites this paper as [47]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Discovery and saturation analysis of cancer genes across 21 tumour types
Lawrence, M. S., Stojanov, P., Mermel, C. H., Robinson, J. T., Garraway, L. A., Golub, T. R., Meyerson, M., Gabriel, S. B., Lander, E. S., & Getz, G. (2014) · Nature · doi:10.1038/nature12912 · Cited by 3,096
Combined Vemurafenib and Cobimetinib in BRAF -Mutated Melanoma
Larkin, J., Ascierto, P. A., Dréno, B., Atkinson, V., Liszkay, G., Maio, M., Mandalà, M., Demidov, L., Stroyakovskiy, D., Thomas, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408868 · Cited by 2,068
Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
Shaw, A. T., Ou, S.-H. I., Bang, Y.-J., Camidge, D. R., Solomon, B. J., Salgia, R., Riely, G. J., Varella-Garcia, M., Shapiro, G. I., Costa, D. B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1406766 · Cited by 1,964
Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma
Wilson, W. H., Young, R. M., Schmitz, R., Yang, Y., Pittaluga, S., Wright, G., Lih, C.-J., Williams, P. M., Shaffer, A. L., Gerecitano, J., et al. (2015) · Nature Medicine · doi:10.1038/nm.3884 · Cited by 1,113
Self-citationSharing Clinical Trial Data: A Proposal From the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · JAMA · doi:10.1001/jama.2015.18164 · Cited by 254
Sharing Clinical Trial Data — A Proposal from the International Committee of Medical Journal Editors
Taichman, D. B., Backus, J., Baethge, C., Bauchner, H., de Leeuw, P. W., Drazen, J. M., Fletcher, J., Frizelle, F. A., Groves, T., Haileamlak, A., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejme1515172 · Cited by 190
Cited by
Items 301–400 of 1,004
High-throughput gene screen reveals modulators of nuclear shape
Tamashunas, A. C., Tocco, V. J., Matthews, J., Zhang, Q., Atanasova, K. R., Paschall, L., Pathak, S. P., Ratnayake, R., Stephens, A. D., Luesch, H., et al. (2020) · Molecular Biology of the Cell · doi:10.1091/mbc.e19-09-0520 · Cited by 44
“TP53 is mutated in 92.98% of uterine carcinomas, 91.51% of ovarian serous cystadenocarcinomas, and 36.51% of all breast cancers with most mutations being loss-of-function (Grossman et al., 2016).”
BackgroundInfluentialPan-Cancer Prognosis Prediction Using Multimodal Deep Learning
Silva, L. A. V., & Rohr, K. (2020) · IEEE International Symposium on Biomedical Imaging (ISBI) · doi:10.1109/isbi45749.2020.9098665 · Cited by 44
“We use data from The Cancer Genome Atlas (TCGA) [10], which includes a rich body of imaging, clinical, and molecular data for patients diagnosed with one of 33 different cancers.”
MethodAlkallas, R., Lajoie, M., Moldoveanu, D., Hoang, K. V., Lefrançois, P., Lingrand, M., Ahanfeshar-Adams, M., Watters, K. A., Spatz, A., Zippin, J. H., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-0077-8 · Cited by 44
Baicalein suppresses growth of non-small cell lung carcinoma by targeting MAP4K3
Li, J., Yan, L., Luo, J., Li, T., Gao, Y., Feng, W., Wang, F., Cui, W., Li, S., & Sun, Z. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110965 · Cited by 44
Longitudinal big biological data in the AI era
Mardinoğlu, A., Türkez, H., Shong, M., Srinivasulu, V. P., Nielsen, J., Palsson, B. Ø., Hood, L., & Uhlén, M. (2025) · Molecular Systems Biology · doi:10.1038/s44320-025-00134-0 · Cited by 43
Jalaleddine, N., El‐Hajjar, L., Dakik, H., Shaito, A. A., Saliba, J. L., Safi, R., Zibara, K., & El-Sabban, M. E. (2019) · Cancers · doi:10.3390/cancers11121967 · Cited by 43
“BRCA RNAseq data were acquired from The Cancer Genome Atlas (TCGA) database [87].”
MethodSong, M. J., & Zhong, H. (2020) · Bioinformatics · doi:10.1093/bioinformatics/btaa613 · Cited by 43
Co-expression analysis of pancreatic cancer proteome reveals biology and prognostic biomarkers
Mantini, G., Vallés‐Martí, A., Large, T. Y. S. L., Capula, M., Funel, N., Pham, T. V., Piersma, S. R., Kazemier, G., Bijlsma, M. F., Giovannetti, E., et al. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00548-y · Cited by 44
“Meta-analysis was carried out by applying univariate Cox regression, multivariate Cox regression and log-rank tests on our proteomics dataset and on two different transcriptomics datasets (TCGA [24] and Moffitt et al.”
BackgroundMethodReiswich, V., Gorbokon, N., Luebke, A. M., Burandt, E., Menz, A., Kluth, M., Hube‐Magg, C., Wittmer, C., Weidemann, S. A., Fraune, C., et al. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.237 · Cited by 43
“Moreover, the TCGA database described elevated PLAP expression in 60% of 354 gastric adenocarcinomas [1].”
BackgroundChuang, Y.-H., Huang, S., Hung, T.-M., Lin, X.-Y., Lee, J.-Y., Lai, W., & Yang, J. (2021) · Scientific Reports · doi:10.1038/s41598-021-98814-y · Cited by 43
Allele-Specific Genomics is an Orthogonal Feature in the Landscape of Primary Tumors Phenotypes
Ciani, Y., Fedrizzi, T., Prandi, D., Lorenzin, F., Locallo, A., Gasperini, P., Franceschini, G. M., Benelli, M., Elemento, O., Fava, L. L., et al. (2021) · Cell Systems · doi:10.1016/j.cels.2021.10.001 · Cited by 43
“TCGA studies inclusion criteria Via the GDC Data Transfer Tool Client provided by the Genomic Data Commons (GDC) (Grossman et al., 2016), all Whole Exome Sequencing (WES) BAM files of the TCGA collection available on January 2018 were downloaded (N BAM=22,196).”
MethodInfluentialSeo, J., Kim, H., Min, K. I., Kim, C., Kwon, Y., Zheng, Z., Kim, Y., Park, H., Ju, Y. S., Roh, M. R., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29925-x · Cited by 43
Most cancers carry a substantial deleterious load due to Hill-Robertson interference
Tilk, S., Tkachenko, S., Curtis, C. N., Petrov, D. A., & McFarland, C. D. (2022) · eLife · doi:10.7554/elife.67790 · Cited by 43
“CNAs used to identify these peaks were downloaded from the NIH Genomic Data Commons (GDC) (Grossman et al., 2016) in the TCGA cohort.”
MethodInfluentialAutomatic Classification of Pathology Reports using TF-IDF FeaturesPreprint
Kalra, S., Li, L., & Tizhoosh, H. R. (2019) · arXiv (Cornell University) · doi:10.48550/arxiv.1903.07406 · Cited by 43
“Collecting pathology reports: The total of 11,112 pathology reports were downloaded from NCI’s Genomic Data Commons (GDC) dataset in PDF format [10].”
MethodHuang, Z., Kaller, M., & Hermeking, H. (2023) · Cell Death and Differentiation · doi:10.1038/s41418-023-01193-2 · Cited by 42
“Analysis of gene expression and clinical data from public databases For the analysis of human colorectal cancer (CRC) samples, we retrieved expression and clinical data of the TCGA-CRC samples from GDC portal [79] and a large integrated CRC samples from GEO repository [44].”
MethodThangudu, R. R., Holck, M., Singhal, D., Pilozzi, A. R., Edwards, N. J., Rudnick, P. A., Domagalski, M. J., Chilappagari, P., Ma, L., Xin, Y., et al. (2024) · Cancer Research Communications · doi:10.1158/2767-9764.crc-24-0243 · Cited by 42
TP63 isoform expression is linked with distinct clinical outcomes in cancer
Bankhead, A., McMaster, T., Wang, Y., Boonstra, P. S., & Palmbos, P. L. (2020) · EBioMedicine · doi:10.1016/j.ebiom.2019.11.022 · Cited by 42
“Patient clinical metadata was sourced from the GDAC Firehose [18,19].”
MethodThe road towards data integration in human genomics: players, steps and interactions
Bernasconi, A., Canakoglu, A., Masseroli, M., & Ceri, S. (2020) · Briefings in Bioinformatics · doi:10.1093/bib/bbaa080 · Cited by 42
de Santiago, P. R., Blanco, A., Morales, F., Marcelain, K., Harismendy, O., Sjöberg-Herrera, M. K., & Armisén, R. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.118956 · Cited by 42
Tavasoli, N., Rezaee, K., Momenzadeh, M., & Sehhati, M. (2021) · Journal of Computational Design and Engineering · doi:10.1093/jcde/qwab039 · Cited by 42
Iron-mediated epigenetic activation of NRF2 targets
Horniblow, R. D., Pathak, P., Balacco, D. L., Acharjee, A., Llès, E., Gkoutos, G. V., Beggs, A. D., & Tselepis, C. (2021) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2021.108929 · Cited by 42
A Survey on AI Techniques for Thoracic Diseases Diagnosis Using Medical Images
Mostafa, F. A., Elrefaei, L. A., Fouda, M. M., & Hossam, A. (2022) · Diagnostics · doi:10.3390/diagnostics12123034 · Cited by 42
“NCI Genomic Data Commons [61,82] Lung Cancer Histopathology More than 575,000 images with size 512 × 512.”
BackgroundMethodPatient Graph Deep Learning to Predict Breast Cancer Molecular Subtype
Furtney, I., Bradley, R. M., & Kabuka, M. R. (2023) · IEEE Transactions on Computational Biology and Bioinformatics · doi:10.1109/tcbb.2023.3290394 · Cited by 42
“Our work utilizes The Cancer Genome Atlas Breast Invasive Carcinoma (TCGA-BRCA) dataset, which contains clinical, genomic, and pathological data in the Genomic Data Commons and radiological data from The Cancer Imaging Archive [46], [47], [48].”
MethodDeveloping Cancer Informatics Applications and Tools Using the NCI Genomic Data Commons API
Wilson, S., Fitzsimons, M., Ferguson, M. L., Heath, A. P., Jensen, M. A., Miller, J., Murphy, M. W., Porter, J., Sahni, H., Staudt, L. M., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0598 · Cited by 42
“The NCI Genomic Data Commons (GDC) was launched in 2016 andmakes available over 4 petabyte (PB) of cancer genomic and associated clinical data to the research community (1).”
BackgroundSelf-citationMAPT (Tau) expression is a biomarker for an increased rate of survival for low‑grade glioma
Zaman, S., Chobrutskiy, B. I., Sikaria, D., & Blanck, G. (2018) · Oncology Reports · doi:10.3892/or.2018.6896 · Cited by 42
Association of imputed prostate cancer transcriptome with disease risk reveals novel mechanisms
Emami, N. C., Kachuri, L., Meyers, T. J., Das, R., Hoffman, J., Hoffmann, T. J., Hu, D., Shan, J., Feng, F. Y.-C., Ziv, E., et al. (2019) · Nature Communications · doi:10.1038/s41467-019-10808-7 · Cited by 43
Pataki, B., Olar, A., Ribli, D., Pesti, A., Kontsek, E., Gyöngyösi, B., Bilecz, Á., Kovács, T., Kovács, K. A., Kramer, Z., et al. (2022) · Scientific Data · doi:10.1038/s41597-022-01450-y · Cited by 42
Haque, S., Niu, L., Kuhnell, D., Hendershot, J. M., Biesiada, J., Niu, W., Hagan, M., Kelsey, K. T., Casper, K. A., Wise-Draper, T. M., et al. (2018) · Head & Neck · doi:10.1002/hed.25136 · Cited by 41
“h38 GENCODE version 22 GTF file were downloaded from the National Cancer Institute (NCI) Genomic Data Commons(19) using the TCGAbiolinks Bioconductor package.(20) Normalized counts (count per million) for each of the 7 lncRNA in each sample were calculated using the cpm function in the Bioconductor package edgeR.”
MethodComputing Skin Cutaneous Melanoma Outcome From the HLA-Alleles and Clinical Characteristics
Dhall, A., Patiyal, S., Kaur, H., Bhalla, S., Arora, C., & Raghava, G. P. S. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00221 · Cited by 41
“Specifically, the whole-exome sequencing (WXS) BAM files of individual melanoma patients were downloaded [under the approval of dbGap (Project No. 17674)] according to the GDC protocols (Grossman et al., 2016) with the help of an in-house high-performance computing (HPC) facility and scripts.”
MethodEBV miRNAs are potent effectors of tumor cell transcriptome remodeling in promoting immune escape
Ungerleider, N., Bullard, W. L., Kara, M., Wang, X., Roberts, C., Renne, R., Tibbetts, S. A., & Flemington, E. K. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009217 · Cited by 41
“Clinical data Aligned RNA and miRNA sequencing reads, deposited by the BGLSP and TCGA, were downloaded from the Genomic Data Commons (GDC)(43).”
MethodPyko, J., Rosemann, J., Müller, L., Kappler, M., Eckert, A. W., Glaß, M., Misiak, D., Hüttelmaier, S., Ballhausen, W. G., Hatzfeld, M., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01384-w · Cited by 41
Chua, K. P., Teng, Y. H. F., Tan, A. C., Takano, A. M., Alvarez, J. J. S., Nahar, R. R., Rohatgi, N., Lai, G. G. Y., Aung, Z. W., Yeong, J. P.-S., et al. (2021) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-20-4607 · Cited by 41
“For TCGA-LUAD RNA-seq data, we downloaded the upper-quartile normalized (FPKM-UQ) expression matrix from GDC (31).”
MethodEnvironmental and sex-specific molecular signatures of glioma causation
Claus, E. B., Cannataro, V. L., Gaffney, S. G., & Townsend, J. P. (2021) · Neuro-Oncology · doi:10.1093/neuonc/noab103 · Cited by 40
“UV light (7b) Defecti e mismatch repair (15) UV light (7d) UV light (7c)”
BackgroundZhang, Y., Manjunath, M., Zhang, S., Chasman, D. A., Roy, S., & Song, J. S. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-3486 · Cited by 40
“The following data were obtained from the NCI Genomic Data Commons (GDC) Legacy Archive (17): 693 patients' tumor copy number segmentation data, 788 patients' processed tumor gene expression data, and 795 ERþ breast cancer patients' tumor RNA-seq raw reads.”
Geeleher, P., Nath, A., Wang, F., Zhang, Z., Barbeira, A., Fessler, J. L., Grossman, R. L., Seoighe, C., & Huang, R. S. (2018) · Genome biology · doi:10.1186/s13059-018-1507-0 · Cited by 41
Self-citationJohnson, T. S., Li, S., Franz, E., Huang, Z., Li, S. D., Campbell, M. J., Huang, K., & Zhang, Y. (2019) · GigaScience · doi:10.1093/gigascience/giz046 · Cited by 40
“of PGG co-expression and miRNA binding (including binding prediction with Miranda [37], PicTar [38], and TargetScan [39]) using The Cancer Genome Atlas (TCGA) and GTEx (GenotypeTissue Expression) Project–derived public data [20, 40, 41].”
Substantial batch effects in TCGA exome sequences undermine pan-cancer analysis of germline variants
Rasnic, R., Brandes, N., Zuk, O., & Linial, M. (2019) · BMC Cancer · doi:10.1186/s12885-019-5994-5 · Cited by 41
“Aligned sequence data for normal samples in BAM file format and the accompanying metadata was downloaded from GDC portal [22].”
DeePathology: Deep Multi-Task Learning for Inferring Molecular Pathology from Cancer Transcriptome
Azarkhalili, B., Saberi, A., Chitsaz, H., & Sharifi‐Zarchi, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-52937-5 · Cited by 40
“One of the largest databases of cancer transcriptome, genome and epigenome profiles is Genomic Data Commons (GDC) that includes The Cancer Genome Atlas (TCGA) and Therapeutically Applicable Research to Generate Effective Treatments (TARGET) programs 18 .”
BackgroundMethodBoos, S. L., Loevenich, L. P., Vosberg, S., Engleitner, T., Öllinger, R., Kumbrink, J., Rokavec, M., Michl, M., Greif, P. A., Jung, A., et al. (2021) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2021.10.008 · Cited by 40
“Data Availability Gene expression data of colorectal adenocarcinoma and rectal adenocarcinoma used for comparison of AURKA gene expression between cancerous and normal tissues were obtained from Genomic Data Commons (GDC)-TCGA data sets.(61) Gene expression changes in CT–PDTOs compared with PDTOs are detailed in Suppl…”
MethodSomatic XIST activation and features of X chromosome inactivation in male human cancers
Sadagopan, A., Nasim, I. T., Li, J., Achom, M., Zhang, C., & Viswanathan, S. R. (2022) · Cell Systems · doi:10.1016/j.cels.2022.10.002 · Cited by 40
Zoli, M., Staartjes, V. E., Guaraldi, F., Friso, F., Rustici, A., Asioli, S., Sollini, G., Pasquini, E., Regli, L., Serra, C., et al. (2020) · Neurosurgical FOCUS · doi:10.3171/2020.3.focus2060 · Cited by 40
MLOmics: Cancer Multi-Omics Database for Machine Learning
Yang, Z., Kotoge, R., Piao, X., Chen, Z., Zhu, L., Gao, P., Matsubara, Y., Sakurai, Y., & Sun, J. (2025) · Scientific Data · doi:10.1038/s41597-025-05235-x · Cited by 41
de Mendonça, M. L., Coletti, R., Gonçalves, C. S., Martins, E. P., Costa, B. M., Vinga, S., & Lopes, M. B. (2025) · Scientific Data · doi:10.1038/s41597-025-05117-2 · Cited by 40
“We have downloaded the latest Firehose data release available (2016-01-28), as it coincides with the latest clinical data available at the GDC Data Portal 16 .”
InfluentialGenome-Scale Metabolic Modeling of Glioblastoma Reveals Promising Targets for Drug Development
Larsson, I., Uhlén, M., Zhang, C., & Mardinoğlu, A. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00381 · Cited by 39
The Exceptional Responders Initiative: Feasibility of a National Cancer Institute Pilot Study
Conley, B. A., Staudt, L., Takebe, N., Wheeler, D. A., Wang, L., Cardenas, M., Korchina, V., Zenklusen, J. C., McShane, L. M., Tricoli, J. V., et al. (2020) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djaa061 · Cited by 40
“Data Commons (12) and made available to other investigators, except those data subject to confidentiality agreements from certain clinical trials (which can be obtained with appropriate permissions).”
BackgroundSelf-citationBudczies, J., Kluck, K., Beck, S., Ourailidis, I., Allgäuer, M., Menzel, M., Kazdal, D. N., Perkhofer, L., Kleger, A., Schirmacher, P., et al. (2022) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.271 · Cited by 39
“Allele-specific copy numbers estimated from SNP array data using the ASCAT algorithm were obtained from the GDC Data Portal [22].”
MethodLoevenich, L. P., Tschurtschenthaler, M., Rokavec, M., Silva, M. G., Jesinghaus, M., Kirchner, T., Klauschen, F., Saur, D., Neumann, J. H. L., Hermeking, H., et al. (2022) · Cancer Research · doi:10.1158/0008-5472.can-22-1247 · Cited by 40
“Gene expression data [upper quartile (UQ) normalized fragments per kilobase of exon per million mapped fragments (FKPM)] of colon adenocarcinoma (COAD) and rectum adenocarcinoma (READ) were obtained fromGDC-TheCancerGenome Atlas(TCGA)datasets(23).”
InfluentialCopy number profiling across glioblastoma populations has implications for clinical trial design
Cimino, P. J., McFerrin, L. G., Wirsching, H., Arora, S., Bolouri, H., Rabadán, R., Weller, M., & Holland, E. C. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy108 · Cited by 40
The Importance — and the Complexities — of Data Sharing
Drazen, J. M., Morrissey, S., Malina, D., Hamel, M. B., & Campion, E. W. (2016) · New England Journal of Medicine · doi:10.1056/nejme1611027 · Cited by 36
Titration of RAS alters senescent state and influences tumour initiation
Chan, A. S. L., Zhu, H., Narita, M., Cassidy, L. D., Young, A. R. J., Bermejo‐Rodríguez, C., Janowska, A. T., Chen, H., Gough, S., Oshimori, N., et al. (2024) · Nature · doi:10.1038/s41586-024-07797-z · Cited by 38
“Next, we performed Kaplan–Meier analysis of patients with HCC from the TCGA dataset 25 , comparing between patients in the top and bottom quartiles of expression levels for each of the subclass signatures.”
InfluentialImplications of epigenetic drift in colorectal neoplasia
Luebeck, G., Hazelton, W., Curtius, K., Maden, S. K., Yu, M., Carter, K. T., Burke, W., Lampe, P., Li, C. I., Ulrich, C., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1682 · Cited by 29
“(2, 31) and The Cancer Genome Atlas (TCGA) consortium Colorectal 146 Adenocarcinoma (COAD) and Rectum Adenocarcinoma (READ) projects (32, 33) to evaluate 147 drift-related methylation patterns in neoplastic tissues.”
WWOX Inhibits Metastasis of Triple-Negative Breast Cancer Cells via Modulation of miRNAs
Khawaled, S., Suh, S. S., Abdeen, S. K., Monin, J., Distefano, R., Nigita, G., Croce, C. M., & Aqeilan, R. I. (2019) · Cancer Research · doi:10.1158/0008-5472.can-18-0614 · Cited by 38
Mjelle, R., Sjursen, W., Thommesen, L., Sætrom, P., & Hofsli, E. (2019) · BMC Cancer · doi:10.1186/s12885-019-5330-0 · Cited by 39
Vlachavas, E., Bohn, J. R., Ückert, F., & Nürnberg, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062822 · Cited by 38
“Based on the latest data summary (October 27, 2020), this data-driven platform contains 67 projects, 68 different cancer types with more than 84 thousand cases, along with clinical data [32].”
MethodBerglund, A., Putney, R. M., Hamaidi, I., & Kim, S. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00612-z · Cited by 38
Deep learning features encode interpretable morphologies within histological images
pour, A. F., White, B. S., Park, J., Sheridan, T., & Chuang, J. H. (2022) · Scientific Reports · doi:10.1038/s41598-022-13541-2 · Cited by 38
Lau, D., Khare, S., Stein, M. M., Jain, P., Gao, Y., BenTaieb, A., Rand, T., Salahudeen, A. A., & Khan, A. A. (2022) · Nature Communications · doi:10.1038/s41467-022-31769-4 · Cited by 38
Novoplansky, O., Shnerb, A. B., Marripati, D., Jagadeeshan, S., Shareb, R. A., Conde‐López, C., Zorea, J., Prasad, M., Lulu, T. B., Yegodayev, K. M., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13500 · Cited by 37
“Bulk RNA sequencing (RNA-seq) and clinical data from HPV16-negative TCGA-HNSC patients were obtained from the GDC Data Portal, publicly available HNSCC cell line data was obtained from the Cancer Cell Line Encyclopedia (CCLE) database [20,21].”
MethodHan, J., Jeong, H., Choi, J., Kim, H., Kwon, T., Myung, K., Park, K., Park, J. I., Sánchez, S., Jung, D., et al. (2025) · Advanced Science · doi:10.1002/advs.202407871 · Cited by 37
Weigert, O., & Weinstock, D. M. (2017) · Blood · doi:10.1182/blood-2017-07-737353 · Cited by 37
Histone 4 Lysine 20 Methylation: A Case for Neurodevelopmental Disease
Wickramasekara, R. N., & Stessman, H. A. F. (2019) · Biology · doi:10.3390/biology8010011 · Cited by 37
“Data points represent single nucleotide variants (SNVs) identified within NDD [73,77,79,80], cancer [81], or control (missense or in-frame deletions) [78] populations.”
BackgroundAhmad, R. M., Ali, B. R., Al-Jasmi, F. A., Sinnott, R., Dhaheri, N. A., & Mohamad, M. S. (2023) · Briefings in Bioinformatics · doi:10.1093/bib/bbad479 · Cited by 37
“These publicly available cancer genetic databases enable the advancement of diagnostic technologies, treatment guidelines and support [62, 75].”
Peterson, Y. K., Nasarre, P., Bonilla, I. V., Hilliard, E., Samples, J. E., Morinelli, T. A., Hill, E. G., & Klauber‐DeMore, N. (2017) · Angiogenesis · doi:10.1007/s10456-017-9574-5 · Cited by 37
“Using the heterodimeric X-ray of Wnt8 and FZD8 (PDB: 4f0A) [26], a 3D molecular homology model was built in order to better understand the critical binding domains for these two proteins.”
BackgroundTumorigenesis as the Paradigm of Quasi-neutral Molecular Evolution
Chen, B., Shi, Z., Chen, Q., Shen, X., Shibata, D. K., Wen, H., & Wu, C. (2019) · Molecular Biology and Evolution · doi:10.1093/molbev/msz075 · Cited by 36
Rendleman, M. C., Buatti, J. M., Braun, T. A., Smith, B. J., Nwakama, C., Beichel, R., Brown, B., & Casavant, T. L. (2019) · BMC Bioinformatics · doi:10.1186/s12859-019-2929-8 · Cited by 36
“The Cancer Genome Atlas (TCGA) Research Network [8] is a coordinated effort to gather, share, and analyze next generation molecular sequencing data to improve our understanding of cancer mechanisms on a molecular level [9].”
BackgroundKolbe, A. R., Bendall, M. L., Pearson, A. T., Paul, D., Nixon, D. F., Pérez‐Losada, M., & Crandall, K. A. (2020) · Viruses · doi:10.3390/v12090956 · Cited by 36
“A total of 43 head and neck cancer cases with paired tumor and healthy tissue samples were downloaded from the Genomic Data Commons (GDC) Data Portal [26].”
MethodFOXM1 drives HPV+ HNSCC sensitivity to WEE1 inhibition
Diab, A., Gem, H., Swanger, J., Kim, H. Y., Smith, K., Zou, G., Raju, S. C., Kao, M. C., Fitzgibbon, M., Loeb, K. R., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013921117 · Cited by 36
“Commons (31) and again found that the FOXM1-target genes studied above were overexpressed in HPV+ HNSCC vs.”
BackgroundBIC: a database for the transcriptional landscape of bacteria in cancer
Chen, K.-P., Hsu, C., Oyang, Y., Huang, H., & Juan, H. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac891 · Cited by 36
“The TCGA miRNA-seq BAM files were retrieved from the NCI Genomic Data Commons (GDC) using the GDC Data Transfer Tool (20).”
MethodWang, J., Ye, Q., Liu, L., Guo, N. L., & Hu, G. (2024) · npj Precision Oncology · doi:10.1038/s41698-024-00576-z · Cited by 35
“Forthe “ Clonal ” casestudy,somaticmutationsinapairofprimaryand recurrenttumorsfromanMMpatient(ID:1201)intheMMRF-CoMMpass studyweresourcedfromtheGDCdataportal 36 .”
Molecular Network Profiling in Intestinal- and Diffuse-Type Gastric Cancer
Tanabe, S., Quader, S., Ono, R., Cabral, H., Aoyagi, K., Hirose, A., Yokozaki, H., & Sasaki, H. (2020) · Cancers · doi:10.3390/cancers12123833 · Cited by 35
Integrated Characterization of lncRNA-Immune Interactions in Prostate Cancer
Hu, W., Wang, Y., Fang, Z., He, W., & Li, S. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.641891 · Cited by 35
Vladimirova, U., Rumyantsev, P. O., Zolotovskaia, M., Albert, E. A., Abrosimov, A., Slashchuk, K. Y., Алексеевич, Н. П., Chukhacheva, O. S., Гайфуллин, Н., Suntsova, M., et al. (2021) · Heliyon · doi:10.1016/j.heliyon.2021.e06408 · Cited by 35
“Nevertheless, GDC dataset can be used for only a limited number of applications because it contains data for only papillary histotype of thyroid cancer (PC) and does not provide immediate open access to raw reads, thus complicating data analysis and limiting its usefulness.”
BackgroundMethodQattan, A. T., Al‐Tweigeri, T., Alkhayal, W., Suleman, K., Tulbah, A. M., & Amer, S. M. B. (2021) · Genes · doi:10.3390/genes12040549 · Cited by 35
“The miRNA expression quantification data of The Cancer Genome Atlas (TCGA) breast cancers was downloaded from the National Cancer Institute, Genomic Data Commons (NCI-GDC) data portal on December 2020 (https://portal.gdc.cancer.gov (accessed on 17 February 2021); Grossman et al., 2016) [28].”
Uhlig, R., Contreras, H., Weidemann, S. A., Gorbokon, N., Menz, A., Büscheck, F., Luebke, A. M., Kluth, M., Hube‐Magg, C., Hinsch, A., et al. (2021) · The American Journal of Surgical Pathology · doi:10.1097/pas.0000000000001817 · Cited by 35
Page, A. L. L., Ballot, E., Truntzer, C., Dérangère, V., Ilie, A., Rageot, D., Bibeau, F., & Ghiringhelli, F. (2021) · Scientific Reports · doi:10.1038/s41598-021-03206-x · Cited by 35
A deep learning approach reveals unexplored landscape of viral expression in cancer
Elbasir, A., Ye, Y., Schäffer, D. E., Xue, H., Wickramasinghe, J. M., Tsingas, K., Lieberman, P. M., Long, Q., Morris, Q., Zhang, R., et al. (2022) · Nature Communications · doi:10.1038/s41467-023-36336-z · Cited by 36
Jin, D., Liang, S., Shmatko, A., Arnold, A., Horst, D. A., Grünewald, T. G. P., Gerstung, M., & Bai, X. (2024) · Nature Communications · doi:10.1038/s41467-024-46764-0 · Cited by 35
“…transcriptome profiling data utilized in the experiments comes from TCGA project via National Cancer Institute (NCI) Genomic Data Commons Portal [53] and CPTAC project via the Cancer Imaging Archive (TCIA) Pathology Portal, which comprises 12,299 H & E stained whole slide images and…”
MethodCrawford, L. A., Monod, A., Chen, A., Mukherjee, S., & Rabadán, R. (2019) · Figshare · doi:10.6084/m9.figshare.10269596 · Cited by 35
Mariuzza, R. A., Wu, D., & Pierce, B. G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1303304 · Cited by 34
“It is also the most common mutation in any tumor suppressor gene (45).”
BackgroundA real-world multi-center RNA-seq benchmarking study using the Quartet and MAQC reference materials
Wang, D., Liu, Y., Zhang, Y., Chen, Q., Han, Y., Hou, W., Liu, C., Yu, Y., Li, Z., Li, Z., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50420-y · Cited by 34
“The TaqMan datasets for the Quartet samples included absolute, relative gene expression and DEG results (Supplementary Data 7).”
InfluentialVis, D. J., Lewin, J. H., Liao, R. G., Mao, M., André, F., Ward, R. L., Calvo, F. M., Teh, B. T., Camargo, A. A., Knoppers, B. M., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx037 · Cited by 34
“The second most commonly highlighted perceived barrier was lack of interoperability of bioinformatics pipelines, and we have already highlighted how initiatives/activities such as GDC [6], SMCC [7] and the GA4GH API [8] are addressing this challenge.”
BackgroundMethodInvestigating miRNA–lncRNA Interactions: Computational Tools and Resources
Veneziano, D., Marceca, G. P., Bella, S. D., Nigita, G., Distefano, R., & Croce, C. M. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9207-2_14 · Cited by 34
Chen, G., Chen, J., Liu, H., Chen, S., Zhang, Y., Li, P., Thierry‐Mieg, D., Thierry‐Mieg, J., Mattes, W. B., Ning, B., et al. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00299 · Cited by 35
Nitta, S., Kandori, S., Tanaka, K., Sakka, S., Siga, M., Nagumo, Y., Negoro, H., Kojima, T., Mathis, B. J., Shimazui, T., et al. (2022) · Cancer Science · doi:10.1111/cas.15454 · Cited by 34
Kremen1-induced cell death is regulated by homo- and heterodimerization
Sumia, I., Pierani, A., & Causeret, F. (2019) · Cell Death Discovery · doi:10.1038/s41420-019-0175-5 · Cited by 34
Song, X., Ji, J., Gleason, K. J., Yang, F., Martignetti, J. A., Chen, L. S., & Wang, P. (2019) · Molecular & Cellular Proteomics · doi:10.1074/mcp.ra118.001220 · Cited by 32
The Many Faces of Gene Regulation in Cancer: A Computational Oncogenomics Outlook
Lemus, E. H., Reyes-Gopar, H., Enríquez, J. E., & Ochoa, S. (2019) · Genes · doi:10.3390/genes10110865 · Cited by 35
Grosser, B., Heyer, C. M., Austgen, J., Sipos, É., Reitsam, N. G., Hauser, A., VanSchoiack, A., Kroeppler, D., Vlasenko, D., Probst, A., et al. (2023) · Gastric Cancer · doi:10.1007/s10120-023-01436-8 · Cited by 33
“H &E-stained whole slide images (named Dx) were downloaded from TCGA GDC Data Portal and assessed for SARIFA status [16].”
The human intermediate prolactin receptor is a mammary proto-oncogene
Grible, J. M., Zot, P., Olex, A. L., Hedrick, S. E., Harrell, J. C., Woock, A. E., Idowu, M. O., & Clevenger, C. V. (2021) · npj Breast Cancer · doi:10.1038/s41523-021-00243-7 · Cited by 33
Nagumo, Y., Kandori, S., Tanuma, K., Nitta, S., Chihara, I., Shiga, M., Hoshi, A., Negoro, H., Kojima, T., Mathis, B. J., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.04.014 · Cited by 33
Fain, J. S., Loriot, A. E., Diacofotaki, A., Tongelen, A. V., & Smet, C. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-96844-0 · Cited by 33
Zhang, H., Shi, Y., Qing, Y., Wang, C., Xia, Q., Zhang, Y., Jiang, W., & Jia, Q. (2022) · Frontiers in Genetics · doi:10.3389/fgene.2022.975185 · Cited by 34
“The cuproptosis-related gene expression levels and interactions The 13 cuproptosis-related gene expression levels were determined after comparing 59 normal and 526 tumor tissues in GDC TCGA LUAD cohort retrieved from UCSC Xena.”
BackgroundInfluentialCaruso, C. M., Guarrasi, V., Cordelli, E., Sicilia, R., Gentile, S., Messina, L., Fiore, M., Piccolo, C., Beomonte Zobel, B., Iannello, G., et al. (2022) · Journal of Imaging · doi:10.3390/jimaging8110298 · Cited by 31
“The former was approved on 30 October 2012 and registered at ClinicalTrials.gov on 12 July 2018 with Identifier NCT03583723, whilst the latter was approved on 16 April 2019 with Identifier 16/19 OSS, and it was closed on April 2022.”
Subramanian, M., Kabir, A. U., Barisas, D. A. G., Krchma, K., & Choi, K. (2023) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100896 · Cited by 34
Dávalos, V., Lovell, C. D., Itter, R. V., Dolgalev, I., Agrawal, P. K., Baptiste, G. G., Kahler, D. J., Sokolova, E., Morán, S., Piqué, L., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36967-2 · Cited by 33
Svensson, S. F., Halldórsson, S., Latysheva, A., Fuster‐García, E., Hjørnevik, T., Fraser‐Green, J., Bugge, R., Grinband, J., Holm, S., Sinkus, R., et al. (2023) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdad021 · Cited by 33
The evolutionary pattern of mutations in glioblastoma reveals therapy-mediated selection
Muscat, A. M., Wong, N. C., Drummond, K. J., Algar, E. M., Khasraw, M., Verhaak, R., Field, K., Rosenthal, M. A., & Ashley, D. M. (2018) · Oncotarget · doi:10.18632/oncotarget.23541 · Cited by 32
“The NCI Genomic Data Commons (GDC) [26] portal was used to access the MuTect masked somatic mutation MAF file format of the TCGA-GBM dataset (https://gdc-portal.”
Mog, B. J., Marcou, N., DiNapoli, S. R., Pearlman, A. H., Nichakawade, T. D., Hwang, M. S., Douglass, J., Hsiue, E. H.-C., Glavaris, S. A., Wright, K. M., et al. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.adg7123 · Cited by 32
“The TP53 R175H mutation is the most common mutation in TP53, and HLA-A*02:01 is the most common HLA allele in Western populations (54, 55).”
Nuclear speckles regulate functional programs in cancer
Alexander, K. A., Yu, R., Skuli, N., Coffey, N. J., Nguyen, S. C., Faunce, C. L., Huang, H., Dardani, I. P., Good, A. L., Lim, J., et al. (2025) · Nature Cell Biology · doi:10.1038/s41556-024-01570-0 · Cited by 33
LINC01714 Enhances Gemcitabine Sensitivity by Modulating FOXO3 Phosphorylation in Cholangiocarcinoma
Shen, S., Wang, J., Zheng, B., Ying, T., Li, M., Wang, Y., Ni, X., Suo, T., Liu, H., Liu, H., et al. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.11.028 · Cited by 32
“gov/).(31) The raw sequencing reads were aligned to hg38 by the GDC using a two-pass method with STAR aligner.”
Method
Metadata
- Authors
- Grossman, R. L., Heath, A. P., Ferretti, V., Varmus, H. E., Lowy, D. R., Kibbe, W. A., & Staudt, L. M.
- Affiliations
- Ontario Institute for Cancer Research (CA)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2016-09-22
- Volume
- 375
- Issue
- 12
- Pages
- 1109-1112
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC6309165
- OpenAlex
- W2521492299
- Cited by
- 1,680
- References
- 7
- Citations by year
- 2026: 111 · 2025: 141 · 2024: 192 · 2023: 223 · 2022: 231 · 2021: 238 · 2020: 190 · 2019: 171 · 2018: 114 · 2017: 64 · 2016: 5
- FWCI
- 49.40
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Institutes of Health
- National Cancer Institute (Z01BC008905)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer Genomics and Diagnostics
- Physical Sciences › Computer Science › Information Systems › Research Data Management Practices
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Science, Research, and Medicine
- Keywords
- Genomic Data Commons, data sharing, data harmonization, precision oncology, TCGA, targets, bioinformatics pipeline, clinical data standardization, data interoperability
- MeSH terms
- DNA, Neoplasm, Humans, Neoplasms, United States, Genome, Human, National Cancer Institute (U.S.), Precision Medicine, Datasets as Topic
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.